BIOMAT Database Logo BIOMAT Database Logo

Treatment of hypercalcaemia with calcitonin. 1971

T E West, and L Sinclair, and M Joffe, and J L O'Riordan

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007223 Infant A child between 1 and 23 months of age. Infants
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Treatment of hypercalcaemia with porcine calcitonin.
September 1970, The Journal of endocrinology,
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Emergency treatment with calcitonin of hypercalcaemia associated with multiple myeloma.
March 1977, British medical journal,
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Calcitonin in hypercalcaemia.
July 1968, Lancet (London, England),
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Calcitonin in hypercalcaemia.
July 1968, Lancet (London, England),
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Thyrotoxic hypercalcaemia treated with porcine calcitonin.
June 1969, Lancet (London, England),
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
June 1986, British medical journal (Clinical research ed.),
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
[Calcitonin and hypercalcaemia (author's transl)].
January 1978, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Acute treatment with calcitonin in primary hyperparathyroidism and severe hypercalcaemia of other origin.
January 1975, Acta chirurgica Scandinavica,
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Hypercalcaemia and calcitonin inhibit prolactin secretion.
December 1984, Experimental and clinical endocrinology,
T E West, and L Sinclair, and M Joffe, and J L O'Riordan
Multiple paragangliomata secreting catecholamines and calcitonin with intermittent hypercalcaemia.
July 1979, Journal of the Royal Society of Medicine,
Copied contents to your clipboard!